|

Mid-day market update: Gold rises 1.7%; Triterras shares plummet

Midway through trading Thursday, the Dow traded up 0.33% to 30,252.88 while the NASDAQ rose 0.48% to 12,718.52. The S&P also rose, gaining 0.34% to 3,713.93.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 16,980,840 cases with around 307,510 deaths. India confirmed a total of at least 9,956,550 confirmed cases and 144,450 deaths, while Brazil reported over 7,040,600 COVID-19 cases with 183,730 deaths. In total, there were at least 74,346,880 cases of COVID-19 worldwide with over 1,651,730 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Utilities shares climbed 0.9% on Thursday. Meanwhile, top gainers in the sector included Korea Electric Power Corporation KEP 11.67%, up 12%, and Kenon Holdings Ltd NYSEKEN, up 4%.

In trading on Thursday, energy shares fell 0.7%.

Top Headline

Accenture plc CAN 16.26% reported stronger-than-expected results for its first quarter on Thursday.

Accenture posted quarterly earnings of $2.17 per share, beating analysts’ estimates of $2.05 per share. The company’s quarterly sales came in at $11.76 billion, versus expectations of $11.36 billion.

Accenture said it expects Q2 sales of $11.55 billion to $11.95 billion, versus estimates of $11.35 billion. The company projects FY21 adjusted EPS of $8.02-$8.25, versus analysts’ expectations of $8.05.

Equities Trading UP

Scopus BioPharma Inc. SCPS 519.93% shares shot up 498% to $35.42. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.

Shares of Oriental Culture Holding Ltd OCG 77.87% got a boost, shooting 78% to $10.84 as a potential post IPO volatility. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.

Wunong Net Technology Company Limited WNW 80.72% shares were also up, gaining 96% to $127.57 after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.

Equities Trading DOWN

Triterras Inc TRIT 36.97% shares tumbled 37% to $8.37 after confirming it informed a statutory demand for payment was made to Antanium Resources in Singapore. Triterras said in a regulatory filing it was informed that a statutory demand for payment from Antainium Resources (formerly known as Rhodium Resources) was filed by a creditor of Rhodium on Dec. 1.

Shares of BioCardia Inc BCDA 25.34% were down 25% to $4.3288. BioCardia disclosed positive DSMB review and recommendation to continue Phase III pivotal CardiAMP heart failure study as designed. BioCardia recently reported a 1.789 million share registered direct offering priced at $4.75 per share.

SCYNEXIS, Inc. SCYX 18.14% was down, falling 18% to $6.01 after the company announced the launch of $50 million common stock and warrant offering.

Commodities

In commodity news, oil traded up 0.8% to $48.22, while gold traded up 1.7% to $1,890.20.

Silver traded up 4.2% Thursday to $26.105 while copper rose 1% to $3.5955.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.3%, the Spanish Ibex Index rose 0.17%, while Italy’s FTSE MIB Index gained 0.12%. Meanwhile, the German DAX 30 gained 0.75%, French CAC 40 gained 0.03% and London’s FTSE 100 slipped 0.3%.

Eurozone consumer prices declined for a third straight month by 0.3% year-over-year in November, while French manufacturing climate indicator rose to 93 in December versus 92 in November.

Economics

US housing starts rose 1.2% to an annual rate of 1.547 million in November, while building permits rose 6.2% to 1.639 million.

US initial jobless claims climbed to 885,000 in the week ended December 12, versus a revised level of 862,000 in the prior week

The Philadelphia Fed manufacturing index declined to 11.1 in December versus 26.3 in November.

US natural-gas supplies dropped 122 billion cubic feet last week, the Energy Information Administration said.

The Kansas City Fed's manufacturing production index declined by 8 points to a reading of 12 in December.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD deflates to fresh lows, targets 1.1600

The selling pressure on EUR/USD now gathers extra pace, prompting the pair to hit fresh multi-week lows in the 1.1625-1.1620 band on Friday. The continuation of the downward bias comes in response to further gains in the US Dollar as market participants continue to assess the mixed release of US Nonfarm Payrolls in December.

GBP/USD breaks below 1.3400, challenges the 200-day SMA

GBP/USD remains under heavy fire and retreats for the fourth consecutive day on Friday. Indeed, Cable suffers the strong performance of the Greenback, intensified post-mixed NFP, and trades at shouting distance from its critical 200-day SMA near 1.3380.

Gold flirts with yearly tops around $4,500

Gold keeps its positive bias on Friday, adding to Thursday’s advance and challenging yearly highs in the $4,500 region per troy ounce. The risk-off sentiment favours the yellow metal despite the firmer tone in the Greenback and rising US Treasury yields.

Crypto Today: Bitcoin, Ethereum, XRP risk further decline as market fear persists amid slowing demand

Bitcoin holds $90,000 but stays below the 50-day EMA as institutional demand wanes. Ethereum steadies above $3,000 but remains structurally weak due to ETF outflows. XRP ETFs resume inflows, but the price struggles to gain ground above key support.

Week ahead – US CPI might challenge the geopolitics-boosted Dollar

Geopolitics may try to steal the limelight from US data. A possible US Supreme Court ruling on tariffs could dictate market movements. A crammed data calendar next week, US CPI comes on Tuesday; Fedspeak to intensify.

XRP trades under pressure amid weak retail demand

XRP presses down on the 50-day EMA support as risk-averse sentiment spreads despite a positive start to 2026. XRP faces declining retail demand, as reflected in futures Open Interest, which has fallen to $4.15 billion.